Blood stem cells constitute the only lifelong source for the billions of new blood cells produced every day in our body. Since their number is rather very small, maintencance of these stem cells by their capacity to self-renew represents a vital prerequisite for a functional blood and immune system.
Unfortunately, the molecular mechanisms of stem cell self-renewal remain elusive, although a great therapeutical need exists for these cells to be used in stem cell transplantations to treat cancer and blood diseases. This need could be covered by effective expansion of blood stem cells in cell culture, while preserving their full stem cell capacity.
The groups of Martin Zörnig at the Georg-Speyer-Haus in Frankfurt and Michael Rieger at the University Clinic Frankfurt (LOEWE Center for Cell and Gene Therapy and Department of Hematology/Oncology) joined forces and identified the molecule FUSE Binding Protein 1 (FUBP1) as an essential factor for the self-renewal of blood stem cells in a close collaboration.
FUBP1 functions as a transcriptional regulator, which binds to its single-stranded target DNA sequence FUSE upstream of target genes that are activated or repressed upon FUBP1 binding. As a consequence, a whole network of genes is controlled by FUBP1.
Among others, FUBP1 represses the cell cycle inhibitor p21 and the cell death-inducing molecule Noxa, thereby supporting the survival and expansion of the stem cells. Interestingly, FUBP1 is absolutely essential for both, the expansion of blood stem cells during early embryonic development and for their lifelong production in the adult organism. The results of this study are now published in the internationally recognized journal "Cell Reports" (see link below).
Future studies address the question which molecular signal transduction pathways in stem cells are regulated by FUBP1, and how they can be manipulated to improve an efficient blood stem cell expansion in cell culture for therapeutic stem cell transplantations. In additon, the GSH researchers started to investigate whether FUBP1 represents a promising target molecule for cancer therapy to inhibit the fatal self-renewal of cancer stem cells.
Rabenhorst, U.*, Thalheimer, F.B.*, Gerlach, K.*, Kijonka, M., Böhm, S., Krause, D., Vauti, F., Arnold, HH., Schroeder, T., Schnütgen, F., von Melchner, H., Rieger, M.A.#, and Zörnig, M.# "Single-stranded DNA-binding transcriptional regulator FUBP1 is essential for fetal and adult hematopoietic stem cell self-renewal."
Cell Reports 11:1-9 (2015)
* equal first authors
# shared senior authorship
Prof. Dr. Martin Zörnig
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy
60596 Frankfurt, Germany
Christine Kost | idw - Informationsdienst Wissenschaft
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences